MS Briefs

Concussion in adolescents tied to MS risk


 

Key clinical point: Concussions in adolescents correlate to an elevated risk for multiple sclerosis (MS).

Major finding: The risk for MS was higher among patients exposed to a concussion in adolescence (hazard ratio [HR], 1.29; P = .03). Sex-specific analysis revealed a higher risk for MS only in males who sustained a concussion in adolescence (HR, 1.41; P = 0.04).

Study details: Retrospective study included 97,965 patients (age, 11-18 years) exposed to a concussion who were matched to 293,895 unexposed patients; primary outcome was MS diagnosis.

Disclosures: This study was funded by an unrestricted investigator-initiated trial grant from Roche Canada and supported by ICES. The corresponding author has served on advisory boards for Biogen Idec, EMD Serono, Genzyme Canada, Novartis, and Roche; has received Investigator Initiated Grant Funds from Biogen Idec, Novartis, and Roche; and has acted as site PI for multicenter trials funded by Novartis, Genzyme, Roche, and AbbVie. All other authors declared no conflicts of interest.

Citation: Povolo CA et al. Mult Scler. 2020 Feb 24. doi: 10.1177/1352458520908037.

Recommended Reading

Serum GFAP may indicate disease severity in NMOSD
ICYMI Multiple Sclerosis
DMT use is common in older patients with MS
ICYMI Multiple Sclerosis
Manual dexterity may decline more rapidly in pediatric-onset MS
ICYMI Multiple Sclerosis
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MS
ICYMI Multiple Sclerosis
Sexual dysfunction is highly prevalent in women with MS
ICYMI Multiple Sclerosis
Elevated D-dimer after infusion of alemtuzumab in patients with MS
ICYMI Multiple Sclerosis
60% of morbidity comes from 30% of patients with moderate-to-severe MS
ICYMI Multiple Sclerosis
Multidisciplinary rehabilitation can improve highly impacting symptoms of relapse-onset MS
ICYMI Multiple Sclerosis
Cannabis use among patients with MS and spasticity
ICYMI Multiple Sclerosis
Vitamin D levels tied to clinical and radiological outcomes in early relapsing MS
ICYMI Multiple Sclerosis